Domov › Akutna mieločna levkemija › New Jersey › Edison

Klinične študije za Akutna mieločna levkemija v Edison, NJ

20 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Edison in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Vključevanje udeležencevFaza 1

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

Vključevanje udeležencevFaza 1

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2

Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi stran
Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi stran

Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3

Saint Peter's University Hospital, New Brunswick · 3 mi stran
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi stran

6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2

Saint Peter's University Hospital, New Brunswick · 3 mi stran
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi stran

Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241